A year after the county medical examiner ruled Keith Bach’s death in the San Diego Central Jail a homicide due to neglect, ...

Delhi government hospitals face a severe shortage of essential medicines and supplies, forcing patients to purchase basic ...

Topline Phase 3 CATT1 data for cadisegliatin in type 1 diabetes expected second half 2026 $80 million private placement ...

A price freeze is now in effect on basic goods, following President Marcos’ declaration of a state of national calamity, the ...

Q3 2025 Earnings Call Transcript November 6, 2025 Amylyx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $ ...

Since 2023, the U.S. Food and Drug Administration (FDA) has not required animal testing, thanks in part to organoids, which ...

Your hormones reveal much about your health. Imbalances in cortisol, thyroid, insulin, estrogen, progesterone, testosterone, ...

Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to expand access to its obesity medicines and re ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full ...

Announced increased focus on type 1 diabetes and in vivo CAR T programsRegulatory interactions increase confidence in moving forward with GMP ...

(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today reported financial results and provided a business ...

Conference call today at 9:00 am ETQ3 2025 revenues of $82.1M, +17% v. Q3 2024YTD 2025 revenues of $237.0M, +14% v. YTD 2024Completed acquisition of scPharmaceuticals on October 7, accelerating ...